<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Neuraxpharm IE</provider_name><provider_url>https://www.neuraxpharm.com/ie</provider_url><author_name>Increnta</author_name><author_url>https://www.neuraxpharm.com/ie/blog/author/admin</author_url><title>DR. MAXIMILIAN VON W&#xDC;LFING</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="sSfMd64Cpq"&gt;&lt;a href="https://www.neuraxpharm.com/ie/about-us/executive-committee/maximilian-von-wuelfing"&gt;DR. MAXIMILIAN VON W&#xDC;LFING&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.neuraxpharm.com/ie/about-us/executive-committee/maximilian-von-wuelfing/embed#?secret=sSfMd64Cpq" width="600" height="338" title="&#x201C;DR. MAXIMILIAN VON W&#xDC;LFING&#x201D; &#x2014; Neuraxpharm IE" data-secret="sSfMd64Cpq" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.neuraxpharm.com/ie/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><description>https://www.linkedin.com/in/maximilian-von-wuelfing-8975708/ Neuraxpharm DR. MAXIMILIAN VON W&#xDC;LFING Dr. Maximilian von W&#xFC;lfing has over 15 years of international leadership experience in the pharmaceutical industry. He joins Neuraxpharm from Mylan, now Viatris, where he was the General Manager for numerous countries in Europe, his last position being General Manager for Viatris Germany. Previously, he was Head of Global [&hellip;]</description><thumbnail_url>https://www.neuraxpharm.com/ie/wp-content/uploads/sites/21/2023/03/m-wulfing.jpg</thumbnail_url></oembed>
